-Thomas Szekeres Researcher Activity Profile

Research Author Detailed Information 

Thomas Szekeres Publication Rate By Year

Thomas Szekeres has published 1 paper(s) in 1977, 1 paper(s) in 1978, 7 paper(s) in 2007, 3 paper(s) in 2008, for a total of 12 research publications in total.

Thomas T Szekeres Author Information

LAST NAME: szekeres

FIRST NAME: Thomas

INITIALS: t

AFFILIATION:

Papers

Thomas Szekeres's Publication Record

1. N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine. Year Published: 2007
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
2. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Year Published: 2007
Department of Cardiology, Clinical Institute for Medical and Chemical Laboratory Diagnostics, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria.
3. Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines. Year Published: 2007
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
4. Effects of neuromuscular electrical stimulation of the knee extensor muscles on muscle soreness and different serum parameters in young male athletes: preliminary data. Year Published: 2007
Richard Crevenna, Medical University of Vienna, Spitalgasse 23, A-1090, Vienna, Austria; richard.crevenna@meduniwien.ac.at.
5. Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines. Year Published: 2007
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
6. Effects of neuromuscular electrical stimulation of the knee extensor muscles on muscle soreness and different serum parameters in young male athletes: preliminary data. Year Published: 2007
Medical University of Vienna, Spitalgasse 23, A-1090, Vienna, Austria.
7. N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine. Year Published: 2007
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
8. Experimental infection of calves with an adenovirus isolated from sheep and related to bovine Adenovirus type 2 I. Clinical and virological studies. Year Published: 1977
9. Experimental infection of calves with an adenovirus isolated from sheep and related to bovine adenovirus type 2. II. Pathological and histopathological studies. Year Published: 1978
10. Resveratrol and its analogs: Defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Year Published: 2008
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
11. Stilbene analogues affect cell cycle progression and apoptosis independently of each other in an MCF-7 array of clones with distinct genetic and chemoresistant backgrounds. Year Published: 2008
Institute of Clinical Pathology, General Hospital of Vienna, Medical University of Vienna, A-1090 Vienna, Austria.
12. Stilbene analogues affect cell cycle progression and apoptosis independently of each other in an MCF-7 array of clones with distinct genetic and chemoresistant backgrounds. Year Published: 2008
Institute of Clinical Pathology, General Hospital of Vienna, Medical University of Vienna, A-1090 Vienna, Austria.